For condition: Atopic Dermatitis
For condition: Eczema – Atopic Dermatitis
Pediatric Atopic Dermatitis Research Trial (60 Weeks)
Study Summary
Who Can Participate?
Infants and toddlers 3 to 23 months of age (post-natal) with atopic dermatitis (AD), may be eligible.
Inclusion Criteria:
• Meet criteria for a clinical diagnosis of AD as determined by medical evaluation including medical history and physical examination and have AD covering ≥ 5% of the body surface area (BSA) AND have mild, moderate, or severe disease
• Have a legal guardian or primary caregiver that can provide informed consent, and is available to help the participant by accompanying them to study visits, provide information as needed, and dispense study medication
Participant Info:
• No cost to participate or receive study treatment
• Regular visits with study doctors who are familiar with treating pediatric AD
• Will receive investigational topical medication (active study drug) or placebo
• Reimbursement for study-related expenses may be provided
How Long Will The Study Last?
Participation will last about 60 weeks and involve about 18 visits to the study research site
For more information about this trial, please visit ClinicalTrials.gov
